FDA Approves Alli(TM) (orlistat 60 Mg Capsules) Over-The-Counter
Thu, 08 Feb 2007 08:00 AM EST
... GlaxoSmithKline [NYSE:GSK] Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) approved the weight-loss product orlistat 60 mg capsules for over-the-counter (OTC) use in the United States. GSK Consumer Healthcare will market OTC orlistat under the brand name alli(TM) (pronounced AL-eye). [click link for full article] ...
Related Topics
- Over-the-Counter Medicines
- Orlistat
- Brompheniramine and Pseudoephedrine Extended Release
- Fenofibrate Capsules
- Cyanocobalamin Capsules
- Casanthranol and Docusate Sodium
- Sulfinpyrazone Capsules
- Nizatidine capsules
- Drug Safety
- Cromolyn Inhalation Capsules
- Emergency Contraception
- Perindopril
- Levonorgestrel Emergency Contraception
- Vancomycin Capsules
- Tacrolimus ointment
- Omeprazole capsules
- Prometrium
- Calcium Acetate Capsules or Gelcaps
- Clindamycin Capsules
- Carvedilol

Not Signed In -


